AN OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY, AND EFFICACY OF OMBITASVIR (OBV), PARITAPREVIR (PTV), RITONAVIR (RTV) WITH OR WITHOUT DASABUVIR (DSV) AND WITH OR WITHOUT RIBAVIRIN (RBV) IN PEDIATRIC SUBJECTS WITH GENOTYPE 1 OR 4 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION (ZIRCON)

Registry ID
M14-748
Source registry
HEALTH_CANADA
Status
Pending
Study type
INTERVENTIONAL
Sponsor
ABBVIE CORPORATION
Last update
2015-10-22

Conditions

Related clinical trials

View on source registry